8.60
+0.95
+(12.42%)
At close: April 17 at 4:00:01 PM EDT
8.62
+0.02
+(0.23%)
After hours: April 17 at 7:52:44 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
1,091,400
1,304,600
1,268,800
1,581,600
Total Liabilities Net Minority Interest
529,700
644,600
703,900
799,900
Total Equity Gross Minority Interest
561,700
660,000
564,900
781,700
Total Capitalization
562,300
660,800
565,900
782,700
Common Stock Equity
561,700
660,000
564,900
781,700
Capital Lease Obligations
9,100
2,400
4,500
4,000
Net Tangible Assets
561,700
660,000
564,900
781,700
Working Capital
837,500
1,023,100
945,100
1,290,800
Invested Capital
562,300
660,800
565,900
782,700
Tangible Book Value
561,700
660,000
564,900
781,700
Total Debt
9,700
3,200
5,500
5,000
Share Issued
68,800
68,000
53,200
52,871.65
Ordinary Shares Number
68,800
68,000
53,200
52,871.65
12/31/2021 - 9/27/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DAWN Day One Biopharmaceuticals, Inc.
6.84
+1.18%
RLAY Relay Therapeutics, Inc.
2.6900
+3.07%
KYMR Kymera Therapeutics, Inc.
25.97
+3.80%
VIR Vir Biotechnology, Inc.
5.50
+1.20%
RCKT Rocket Pharmaceuticals, Inc.
6.33
+2.93%
CYTK Cytokinetics, Incorporated
39.48
+0.84%
SWTX SpringWorks Therapeutics, Inc.
37.92
+0.48%
GOSS Gossamer Bio, Inc.
0.8425
+1.49%
NUVB Nuvation Bio Inc.
1.9700
+4.79%
KROS Keros Therapeutics, Inc.
14.07
+3.99%